Commerzbank Aktiengesellschaft’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-6,503	Closed	-$971K	–	1165
2015 Q4	$971K	Buy	+6,503	New	+$1.1M	0.01%	663
2015 Q3	–	Sell	-115,076	Closed	-$27.8M	–	1191
2015 Q2	$27.8M	Buy	115,076 +114,288	+14,504%	+$30.4M	0.15%	99
2015 Q1	$222K	Sell	788 -68,285	-99%	-$14.8M	﹤0.01%	1071
2014 Q4	$10.8M	Buy	69,073 +10,055	+17%	+$1.86M	0.07%	246
2014 Q3	$14M	Buy	59,018 +27,144	+85%	+$6.92M	0.06%	248
2014 Q2	$7.54M	Sell	31,874 -126	-0.4%	-$33.2K	0.04%	344
2014 Q1	$10.6M	Sell	32,000 -23,061	-42%	-$7.78M	0.05%	254
2013 Q4	$16.6M	Buy	+55,061	New	+$3.18M	0.08%	166
2013 Q3	–	Sell	-15,100	Closed	-$677K	–	1443
2013 Q2	$677K	Buy	+15,100	New	+$516K	﹤0.01%	995

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Commerzbank Aktiengesellschaft's ICPT Position: Q1 2016 in Review

Commerzbank Aktiengesellschaft sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2016, closing a stake of 6,503 shares — an estimated $971K sold.

Commerzbank Aktiengesellschaft first reported a position in ICPT in Q2 2013 and held it in 9 quarters. The position peaked at $27.8M in Q2 2015. 160 funds tracked by Wall St. Rank hold ICPT as of Q1 2016.

Commerzbank Aktiengesellschaft reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 6,503 Intercept Pharmaceuticals, Inc. shares in Q1 2016, an estimated $971K.
Commerzbank Aktiengesellschaft first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 9 quarters.
Commerzbank Aktiengesellschaft's Intercept Pharmaceuticals, Inc. position peaked at $27.8M in Q2 2015.
160 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2016.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2016, filed 10 May 2016.